Login

Mr. Nitin Verma, CEO of Mirae Asset Global Indices, unveils the future of ETFs at Innowave. 00:10:00

Share On Facebook Share On Twitter

Kim, Mi Seob · President & CEO, Mirae Asset Global Investments

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"COP26 Insights: Decarbonising the Buildings Sector with Daniel Rozier of Lazard Asset Management"
00:10:00
How A/B Dynamics Transformed Its Workspace: A Conversation with CEO Tim Rogers
00:10:00
Leading the Charge: First Investors and Continued Commitment|Calvin Chin,Managing Partner,The E14 Fund
00:10:00
Real Estate Perspectives with Gonzalo de la Serna | Gonzalo de la Serna, CEO, Consultatio SA.
00:10:00
Advancing Nevada Copper: Insights from the One-to-One Conference in London
00:10:00
Listen, strategize, and support our partners as we pursue our shared goals.|Jeffrey Ansell, Strategic Executive Advisor,Vestar Capital Partners
00:10:00
Robert Ogór on AMBRA SA's Wine Market Strategy and Increased Dividend Expectations | Robert Ogór, President, AMBRA SA.
00:10:00
Navarre Minerals: Advancing Gold Exploration in Victoria, Australia with Promising Prospects and Aggressive Growth Plans
00:10:00
Borosil's Business Restructuring: CEO Shreevar Kheruka Discusses Consumer Business Spin-Off | Shreevar Kheruka, CEO, Borosil Ltd.
00:10:00
CEO Luiz Osório Dumoncel on the Company's Growth and Unique Position in Agribusiness | Luiz Osório Dumoncel, CEO, Três Tentos Agroindustrial SA.
00:10:00
Wobin Tribal Council Wins 2024 Skookum Jim Award for Collaborative Mining Model
00:10:00
Brenen Hofstadter of Generational Capital Markets shares insights on mergers and acquisitions, emphasizing deal structuring and advisory services on MandA.TV.

© 2017 - Neuhu+